Research Site

Midland, Michigan 48670

1 studies enrolling now · 13 studies all time

What they study most

Acute Coronary Syndrome, Anemia in Chronic Kidney Disease Patients Not on Dialysis, Carcinoma, Coronary Atherosclerosis, Coronary Heart Disease (CHD), Heart Failure, Hypercholesterolemia, Metastases, Neoplasm, Non-small-cell Lung, Post-Operative Complications in Cardiac Surgery, Relapsed or Refractory Multiple Myeloma

Studies at this site

• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS — Recruiting now
• An Evaluation of Patient Reported Outcomes and Clinical Outcomes — Running, not enrolling
• Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery — Completed
• Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction — Completed
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers — Stopped early
• Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab — Completed
• GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound — Completed
• JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab — Completed
• Iressa Expanded Access Program (EAP) — Completed
• CRESTOR Athero Imaging Head to Head IVUS Study — Completed